Shattuck Labs Stock Today
| STTK Stock | USD 1.10 0.01 0.92% |
Performance0 of 100
| Odds Of DistressLess than 34
|
Shattuck Labs is selling for 1.10 as of the 30th of November 2024. This is a 0.92 percent increase since the beginning of the trading day. The stock's last reported lowest price was 1.1. Shattuck Labs has about a 34 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Shattuck Labs are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of June 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 9th of October 2020 | Category Healthcare | Classification Health Care |
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company was incorporated in 2016 and is headquartered in Austin, Texas. Shattuck Labs operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 47.74 M outstanding shares of which 2.12 M shares are at this time shorted by private and institutional investors with about 1.76 trading days to cover. More on Shattuck Labs
Moving together with Shattuck Stock
Moving against Shattuck Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Shattuck Stock Highlights
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsShattuck Labs can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Shattuck Labs' financial leverage. It provides some insight into what part of Shattuck Labs' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shattuck Labs (STTK) is traded on NASDAQ Exchange in USA. It is located in 500 West 5th Street, Austin, TX, United States, 78701 and employs 75 people. Shattuck Labs is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 52.51 M. Shattuck Labs conducts business under Biotechnology sector and is part of Health Care industry. The entity has 47.74 M outstanding shares of which 2.12 M shares are at this time shorted by private and institutional investors with about 1.76 trading days to cover.
Shattuck Labs currently holds about 214.24 M in cash with (81.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Shattuck Labs Probability Of Bankruptcy
Ownership AllocationShattuck Labs shows a total of 47.74 Million outstanding shares. The majority of Shattuck Labs outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Shattuck Labs to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Shattuck Labs. Please pay attention to any change in the institutional holdings of Shattuck Labs as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Shattuck Ownership Details
Shattuck Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 439.6 K | |
| Northern Trust Corp | 2024-09-30 | 323.7 K | |
| Renaissance Technologies Corp | 2024-09-30 | 250.6 K | |
| Bank Of New York Mellon Corp | 2024-06-30 | 222 K | |
| Two Sigma Investments Llc | 2024-09-30 | 190.3 K | |
| Citadel Advisors Llc | 2024-09-30 | 175.3 K | |
| Dimensional Fund Advisors, Inc. | 2024-09-30 | 172.3 K | |
| Comprehensive Portfolio Management, Llc | 2024-09-30 | 142.5 K | |
| Villere St Denis J & Co Llc | 2024-09-30 | 132.6 K | |
| Fmr Inc | 2024-09-30 | 7.2 M | |
| Redmile Group, Llc | 2024-09-30 | 5.6 M |
Shattuck Labs Historical Income Statement
Shattuck Stock Against Markets
Shattuck Labs Corporate Management
| Conor CPA | Vice Relations | Profile | |
| Thomas PharmD | Senior Affairs | Profile | |
| Andrew MBA | Chief Officer | Profile | |
| Fatima MD | VP Research | Profile | |
| George Fromm | CoChief Officer | Profile | |
| Stephen JD | Corporate Counsel | Profile | |
| Kelli MS | Senior Quality | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shattuck Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Shattuck Stock please use our How to buy in Shattuck Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shattuck Labs. If investors know Shattuck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shattuck Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.53) | Revenue Per Share 0.088 | Quarterly Revenue Growth 7.045 | Return On Assets (0.40) | Return On Equity (0.68) |
The market value of Shattuck Labs is measured differently than its book value, which is the value of Shattuck that is recorded on the company's balance sheet. Investors also form their own opinion of Shattuck Labs' value that differs from its market value or its book value, called intrinsic value, which is Shattuck Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shattuck Labs' market value can be influenced by many factors that don't directly affect Shattuck Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shattuck Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Shattuck Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shattuck Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.